talquetamab as a bridging therapy to car-t treatment | shebli atrash, md | ims 2024
Published 8 days ago • 48 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
2:44
talquetamab use in treating relapsed refractory multiple myeloma | shebli atrash, md | ims 2024
-
6:18
talquetamab and teclistamab in rrmm: updated results from redirectt-1 | yael cohen, md | ims 2024
-
1:03:49
a 2023 update on car-t therapy in myeloma with dr. craig hofmeister
-
10:34
talquetamab - guest lecture
-
55:56
talquetamab side effect management
-
17:55
talquetamab | therapies on the horizon #myeloma
-
14:31
teclistamab - guest lecture
-
4:17
car-t cell therapy cilta-cel for relapsed/refractory myeloma | doris hansen, md | asco 2023
-
0:46
who is eligible for car-t therapy?
-
3:22
talquetamab, cevostamab and car-t in the future treatment of myeloma
-
23:54
car-t cell therapy for multiple myeloma - michaela liedtke, md | mcrt webcast apr 24, 2021
-
9:33
talquetamab | ajai chari, md | ash 2022
-
4:15
who is eligible for car-t therapy? #myeloma
-
0:57
what is car-t cell therapy?
-
1:00
side effects of car t cell therapy
-
1:01
how are imids and celmods being explored in combo with car t-cell therapy? #myeloma
-
16:21
car-t therapy for multiple myeloma | mcrt webcast jan 30, 2021
-
3:47
what is car t-cell therapy?